SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-22-006352
Filing Date
2022-05-05
Accepted
2022-05-05 16:16:02
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 r5222210q.htm   iXBRL 10-Q 396553
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 37500
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 7318
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7323
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 3607
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 3820
12 GRAPHIC p18charta.jpg GRAPHIC 105120
13 GRAPHIC p18chartb.jpg GRAPHIC 143420
  Complete submission text file 0001214659-22-006352.txt   3127618

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hgen-20220331.xsd EX-101.SCH 31743
8 XBRL CALCULATION FILE hgen-20220331_cal.xml EX-101.CAL 16243
9 XBRL DEFINITION FILE hgen-20220331_def.xml EX-101.DEF 137823
10 XBRL LABEL FILE hgen-20220331_lab.xml EX-101.LAB 264551
11 XBRL PRESENTATION FILE hgen-20220331_pre.xml EX-101.PRE 144902
49 EXTRACTED XBRL INSTANCE DOCUMENT r5222210q_htm.xml XML 167410
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 22896471
SIC: 2834 Pharmaceutical Preparations